Jacot, W., Heudel, P., Fraisse, J., Gourgou, S., Guiu, S., Dalenc, F., Pistilli, B., Campone, M., Levy, C., Debled, M., Leheurteur, M., Chaix, M., Lefeuvre, C., Goncalves, A., Uwer, L., Ferrero, J., Eymard, J., Petit, T., Mouret‐Reynier, M., Courtinard, C., Cottu, P., Robain, M., & Mailliez, A. (2019). real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program. International journal of cancer, 145(12), 3359–3369. http://access.bl.uk/ark:/81055/vdc_100093258135.0x000061